📰 ET Markets 🔴 BEARISH 🕒 24 Oct 2026, 10:33 AM IST

Anthropic IPO: What should investors consider when valuing the AI company? Aswath Damodaran explains

⚡ Instant Key Takeaways (TL;DR)

🎯

Core Development: Anthropic IPO: What should investors consider when valuing the AI company? Aswath Damodaran explains

📊

Market & Financial Impact: Anthropic is on track for an IPO expected in mid-November, reporting impressive revenues of $16.3 billion. However, the company faces a staggering net loss of over $80 billion for the year. Valuation expert Aswath Damodaran warns that IPO investor metrics can be erratic and heavily influenced by market sentiment. As Anthropic navigates an evolving business model, investors are advised to look beyond venture capital evaluations for a clearer understanding.

💡

Actionable Insight: 🔴 Bearish Risk: Regulatory scrutiny, profit decline, or sell-off risk may create near-term volatility.

As Anthropic's IPO nears its target date, it it worth remembering that IPOs get priced, and that as a young company with growing revenues and big losses, that pricing will be based on metrics that are buzzy and unfamiliar, from eyeballs in the dotcom era to users in the social media decade to ARR with AI companies...https://t.co/5DXmDGcSTf

Top Trending Stocks: SBI Share Price, Axis Bank Share Price, HDFC Bank Share Price, Infosys Share Price, Wipro Share Price, NTPC Share Price

KYB and KYC: Business behind the wealth creator called ‘Divi’s Lab’ – Part 2, concluding

KYB and KYC: Business behind the wealth creator called “Divi’s Lab” – Part 1

📰

Official Publisher Attribution: This report is aggregated from Economic Times. ZeroLive provides live aggregation, automated sentiment synthesis, and exchange disclosure monitoring for retail market participants.

Read Original Full Coverage on Economic Times ↗

⚡

Get Breaking Stock Alerts & Q-Results on Telegram

Real-time 1200x675 image cards and financial filings delivered instantly.

Join @Zerolive_news ↗

Anthropic IPO: What should investors consider when valuing the AI company? Aswath Damodaran explains

🔥 More Live Market Stories

UK unveils $800 million AI security funding plan

[ZYDUSLIFE] Analysts/Institutional Investor Meet/Con. Call Updates - Zydus Lifesciences Limited

HealthStream director Linda Rebrovick sells $420,000 in stock

Immunovant CTO Jay Stout sells $75,099 in shares

Moonshot curbs hacking ability in new Kimi model as fears grow over AI-powered cyberattacks

[REPRO] Copy of Newspaper Publication - Repro India Limited